CTLA4 and breast carcinoma: Investigation of Treg subsets in blood and primary tumor biopsies from breast cancer patients demonstrated phenotypic similarity between Treg fraction II in blood, corresponding to activated Tregs, and intratumoral Tregs with high expression of CTLA‐4, TIGIT, and ICOS [43].